1 / 4

Pre-Filled Syringes Market, Shares, Strategies and Forecasts, Worldwide, 2014 to 2020

A pre-filled syringe is a medical syringe that comes pre-filled with a specific dosage of medication. Representing one of the fastest growing segments of the injectable drug delivery ecosystem, pre-filled syringes offer significant benefits over the traditional ‘vial and syringe’ format, by increasing dosing accuracy, safety and convenience.

Hexareports
Download Presentation

Pre-Filled Syringes Market, Shares, Strategies and Forecasts, Worldwide, 2014 to 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hexa Reports Market Research Reports and Insightful Company Profiles Global Pre-Filled Syringes Industry 2015 Market Share, Size, Industry Profile, Market Prize, Forecast and Overview A pre-filled syringe is a medical syringe that comes pre-filled with a specific dosage of medication. Representing one of the fastest growing segments of the injectable drug delivery ecosystem, pre-filled syringes offer significant benefits over the traditional ‘vial and syringe’ format, by increasing dosing accuracy, safety and convenience. In addition, pre-filled syringes also offer a variety of economic benefits to pharmaceutical companies including a reduction in drug overfill and waste, which increases the saleable yield of the API (Active Pharmaceutical Ingredient). SNS Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Despite challenges relating to drug stability, manufacturing and competition from other drug delivery technologies, the market is poised for significant growth in the coming years. Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020. Browse Detail Report With TOC @http://www.hexareports.com/report/the-pre-filled-syringes- market-2015-2030-opportunities-challenges-strategies-forecasts/details The “Pre-Filled Syringes Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the pre-filled syringes ecosystem including technology, market drivers, challenges, investment potential, leading therapies, use cases, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for pre-filled syringe unit sales from 2015 through to 2030. The forecasts are further segmented for 4

  2. Hexa Reports Market Research Reports and Insightful Company Profiles horizontal submarkets, 10 drug classes, 5 regions and 13 leading countries. The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report. Key Findings: The report has the following key findings: SNS Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020 Many pre-filled syringe manufacturers now also offer integrated automatic needle shielding or retractable needle options While glass continues to remain the gold standard for pre-filled syringes, the proportion of plastic based pre-filled syringes is expected to increase by 5% between 2015 and 2020, due to concerns of glass breakage and plunger failure A number of pre-filled syringe manufacturers have developed dual and multi chambered syringes, to cater for drugs that must be reconstituted at the point of delivery Pre-filled pen systems and auto-injectors will grow at a CAGR of more than 20% over the next five years Request A Sample copy of This Report @ http://www.hexareports.com/sample/47184 Table of Contents 1 Chapter 1: Introduction 1.1 Executive Summary 1.2 Topics Covered 1.3 Historical Revenue & Forecast Segmentation 1.4 Key Questions Answered 1.5 Key Findings 1.6 Methodology 1.7 Target Audience 1.8 Companies & Organizations Mentioned 2 Chapter 2: An Overview of Pre-filled Syringes 2.1 A Brief History of Pre-Filled Syringes 2.2 Types of Pre-Filled Syringes 2.2.1 Glass based 2.2.2 Plastic based 2.2.3 Glass vs. Plastic: A Comparison

  3. Hexa Reports Market Research Reports and Insightful Company Profiles 2.3 Needle Configuration in Pre-Filled Syringes 2.3.1 Staked-In Needles 2.3.2 Luered Designs 4 Single vs. Multi Chamber Syringes 2.4.1 Single Chamber Syringes 2.4.2 Dual & Multi Chamber Syringes 2.5 Safety Concerns of Pre-Filled Syringes 2.5.1 Regulation Driving Safety-Engineered Devices 2.5.2 Traditional Safety Mechanisms 2.5.3 Modern Solutions & Future Prospects 2.6 Pen Systems and Auto-Injectors: Towards Self-Administration 2.6.1 Pen Systems 2.6.2 Auto-Injectors 2.6.3 Future Prospects 2.7 Market Growth Drivers 2.7.1 Ease of Use: Towards At-Home Care & Self-Administration 2.7.2 Cost Containment & Changing Medical Practices 2.7.3 Decreased Risk of Contamination 2.7.4 Decreased Risk of Needle-Stick Injuries 2.7.5 Reduction in Drug Overfill & Waste: Lowering the Cost Per Dosage Unit 2.7.6 Product Differentiation 2.7.7 Logistical Benefits: Ease of Storage and Shipping 2.8 Market Barriers 2.8.1 Drug Stability & Product Shelf Life 2.8.2 Plunger-Barrel Design Challenges 2.8.3 Material Concerns: Glass vs. Plastic 2.8.4 Challenges from Other Drug Delivery Systems 2.8.5 Regulatory, Quality Control & Safety Challenges 3 Chapter 3: Drug Class Availability & Leading Therapies 3.1 Drug Class Availability in Pre-Filled Syringes 3.1.1 MAbs (Monoclonal Antibodies) 3.1.2 Insulin 3.1.3 Erythropoietins 3.1.4 Interferons 3.1.5 G-CSF agents .1.6 Anticoagulants .1.7 Recombinant Coagulation Factors 3.1.8 Biosimilars and Follow-on Protein Products 3.1.9 Vaccines 3.1.10 Growth Hormones

  4. Hexa Reports Market Research Reports and Insightful Company Profiles 3.2 Leading Pre-Filled Syringe Based Therapies 3.2.1 Insulin Therapies 3.2.1.1 Apipara (Insulin Glulisine) 3.2.1.2 Lantus (Insulin Glargine) 3.2.1.3 Levemir (Insulin Detemir) 3.2.1.4 NovoLog (Insulin Aspart) 3.2.1.5 Humalog (Insulin Lispro) 3.2.2 Rheumatoid Arthritis 3.2.2.1 Humira (Adalimumab) 3.2.2.2 Enbrel (Etanercept) 3.2.3 MS (Multiple Sclerosis) 3.2.3.1 Copaxone (Glatiramer Acetate) 3.2.3.2 Avonex, Rebif & CinnoVex (Interferon Beta 1a) 3.2.4 Growth Hormones 3.2.4.1 Somatropin (Various Brands) 3.2.5 Anticoagulants: Low Weight Molecular Herapins 3.2.5.1 Enoxaparin (Various Brands) 3.2.5.2 Arixtra (Fondaparinux) 3.2.5.3 Fragmin (Dalteparin Sodium) Browse Full Report @ http://www.hexareports.com/report/the-pre-filled-syringes-market-2015- 2030-opportunities-challenges-strategies-forecasts/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/

More Related